Investigate the Safety and Tolerability of AZD6244 + Docetaxel in Japanese Patients With Non-Small Cell Lung Cancer
by on Friday, May 25th, 2012 | No Comments
Conditions: Neoplasms,; Metastatic Cancer,; Non-Small Cell Lung Cancer
Interventions: Drug: AZD6244; Drug: Docetaxel
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting – verified May 2012
See the original post: Investigate the Safety and Tolerability of AZD6244 + Docetaxel in Japanese Patients With Non-Small Cell Lung Cancer